140 related articles for article (PubMed ID: 18843047)
1. CCAAT/enhancer-binding protein beta promotes osteoblast differentiation by enhancing Runx2 activity with ATF4.
Tominaga H; Maeda S; Hayashi M; Takeda S; Akira S; Komiya S; Nakamura T; Akiyama H; Imamura T
Mol Biol Cell; 2008 Dec; 19(12):5373-86. PubMed ID: 18843047
[TBL] [Abstract][Full Text] [Related]
2. The RUNX2 cistrome in osteoblasts: characterization, down-regulation following differentiation, and relationship to gene expression.
Meyer MB; Benkusky NA; Pike JW
J Biol Chem; 2014 Jun; 289(23):16016-31. PubMed ID: 24764292
[TBL] [Abstract][Full Text] [Related]
3. Runx1 up-regulates chondrocyte to osteoblast lineage commitment and promotes bone formation by enhancing both chondrogenesis and osteogenesis.
Tang CY; Chen W; Luo Y; Wu J; Zhang Y; McVicar A; McConnell M; Liu Y; Zhou HD; Li YP
Biochem J; 2020 Jul; 477(13):2421-2438. PubMed ID: 32391876
[TBL] [Abstract][Full Text] [Related]
4. Progressive recruitment of Runx2 to genomic targets despite decreasing expression during osteoblast differentiation.
Pregizer S; Baniwal SK; Yan X; Borok Z; Frenkel B
J Cell Biochem; 2008 Nov; 105(4):965-70. PubMed ID: 18821584
[TBL] [Abstract][Full Text] [Related]
5. Misexpression of CCAAT/enhancer binding protein beta causes osteopenia.
Zanotti S; Stadmeyer L; Smerdel-Ramoya A; Durant D; Canalis E
J Endocrinol; 2009 May; 201(2):263-74. PubMed ID: 19218285
[TBL] [Abstract][Full Text] [Related]
6. FoxO1 protein cooperates with ATF4 protein in osteoblasts to control glucose homeostasis.
Kode A; Mosialou I; Silva BC; Joshi S; Ferron M; Rached MT; Kousteni S
J Biol Chem; 2012 Mar; 287(12):8757-68. PubMed ID: 22298775
[TBL] [Abstract][Full Text] [Related]
7. Slug gene expression supports human osteoblast maturation.
Lambertini E; Lisignoli G; Torreggiani E; Manferdini C; Gabusi E; Franceschetti T; Penolazzi L; Gambari R; Facchini A; Piva R
Cell Mol Life Sci; 2009 Nov; 66(22):3641-53. PubMed ID: 19756381
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic histone modifications and master regulators as determinants of context dependent nuclear receptor activity in bone cells.
Pike JW; Meyer MB; St John HC; Benkusky NA
Bone; 2015 Dec; 81():757-764. PubMed ID: 25819039
[TBL] [Abstract][Full Text] [Related]
9. RUNX2 promotes the suppression of osteoblast function and enhancement of osteoclast activity by multiple myeloma cells.
Huang B; Liu H; Chan S; Liu J; Gu J; Chen M; Kuang L; Li X; Zhang X; Li J
Med Oncol; 2023 Mar; 40(4):115. PubMed ID: 36897488
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional upregulation of DDR2 by ATF4 facilitates osteoblastic differentiation through p38 MAPK-mediated Runx2 activation.
Lin KL; Chou CH; Hsieh SC; Hwa SY; Lee MT; Wang FF
J Bone Miner Res; 2010 Nov; 25(11):2489-503. PubMed ID: 20564243
[TBL] [Abstract][Full Text] [Related]
11. Machine learning-based endoplasmic reticulum-related diagnostic biomarker and immune microenvironment landscape for osteoarthritis.
Liu T; Li X; Pang M; Wang L; Li Y; Sun X
Aging (Albany NY); 2024 Feb; 16(5):4563-4578. PubMed ID: 38428406
[TBL] [Abstract][Full Text] [Related]
12. The role of E3 ubiquitin ligases in bone homeostasis and related diseases.
Dong Y; Chen Y; Ma G; Cao H
Acta Pharm Sin B; 2023 Oct; 13(10):3963-3987. PubMed ID: 37799379
[TBL] [Abstract][Full Text] [Related]
13. Bone repair and key signalling pathways for cell-based bone regenerative therapy: A review.
Nasir NJN; Arifin N; Noordin KBAA; Yusop N
J Taibah Univ Med Sci; 2023 Dec; 18(6):1350-1363. PubMed ID: 37305024
[TBL] [Abstract][Full Text] [Related]
14. Targeting Transcription Factors ATF5, CEBPB and CEBPD with Cell-Penetrating Peptides to Treat Brain and Other Cancers.
Greene LA; Zhou Q; Siegelin MD; Angelastro JM
Cells; 2023 Feb; 12(4):. PubMed ID: 36831248
[TBL] [Abstract][Full Text] [Related]
15. A stay of execution: ATF4 regulation and potential outcomes for the integrated stress response.
Neill G; Masson GR
Front Mol Neurosci; 2023; 16():1112253. PubMed ID: 36825279
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of FOXA1 enhances the osteogenic differentiation of human bone marrow mesenchymal stem cells partly via activation of the ERK1/2 signalling pathway.
Li L; Wang Y; Wang Z; Xue D; Dai C; Gao X; Ma J; Hang K; Pan Z
Stem Cell Res Ther; 2022 Sep; 13(1):456. PubMed ID: 36064451
[TBL] [Abstract][Full Text] [Related]
17. Biology of Activating Transcription Factor 4 (ATF4) and Its Role in Skeletal Muscle Atrophy.
Ebert SM; Rasmussen BB; Judge AR; Judge SM; Larsson L; Wek RC; Anthony TG; Marcotte GR; Miller MJ; Yorek MA; Vella A; Volpi E; Stern JI; Strub MD; Ryan Z; Talley JJ; Adams CM
J Nutr; 2022 Apr; 152(4):926-938. PubMed ID: 34958390
[TBL] [Abstract][Full Text] [Related]
18. Metabolic and Transcriptional Changes across Osteogenic Differentiation of Mesenchymal Stromal Cells.
Sigmarsdottir TB; McGarrity S; de Lomana ALG; Kotronoulas A; Sigurdsson S; Yurkovich JT; Rolfsson O; Sigurjonsson OE
Bioengineering (Basel); 2021 Dec; 8(12):. PubMed ID: 34940360
[TBL] [Abstract][Full Text] [Related]
19. Genome-scale actions of master regulators directing skeletal development.
Ohba S
Jpn Dent Sci Rev; 2021 Nov; 57():217-223. PubMed ID: 34745394
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
